Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA-seq of BJ human fibroblasts treated with doxorubicin or abemaciclib compared to vehicle-treated counterpart

ABSTRACT: RNA-seq of BJ human fibroblasts treated with doxorubicin or abemaciclib compared to vehicle-treated counterpart

PROVIDER: PRJEB31056 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR3137010_1.fastq.gz	Fastqsanger.gz
	ERR3137010_2.fastq.gz	Fastqsanger.gz
	ERR3137011_1.fastq.gz	Fastqsanger.gz
	ERR3137011_2.fastq.gz	Fastqsanger.gz
	ERR3137012_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 30

Similar Datasets

RNA-seq of BJ human fibroblasts treated with doxorubicin or abemaciclib compared to vehicle-treated counterpart

Project description:This experiment follows the transcriptional response of human fibroblasts (BJ) to two different drug treatments (doxorubicin and abemaciclib) in comparison to treatment with vehicle (water). The two drugs are used in cancer care and their mechanism of action entails proliferative arrest. Doxorubicin is a member of the anthracycline family and acts as a topoisomerase II inhibitor. Abemaciclib is an inhibitor of the Cyclin Dependent Kinases (CDK) 4/6 which arrest cell cycle at the G1/S phase.

2021-11-29 | E-MTAB-7642 | biostudies-arrayexpress

Proteomic analysis of GC7-treated senescent and proliferating BJ fibroblasts

Project description:Quantitative analysis of global proteomic changes in proliferating and senescent BJ fibroblasts, treated with eIF5A hypusination inhibitor GC7 (10 uM) for 12h.

2024-07-12 | PXD034251 | Pride

Nascent proteome analysis of proliferating and senescent BJ fibroblast treated with GC7

Project description:Analysis of proteomic changes in proliferating and senescent BJ fibroblast treated with eIF5A hypusination inhibitor GC7 for 12h.

2024-07-12 | PXD034334 | Pride

ATAC-seq of mESC treated with doxorubicin

Project description:E14 mESC were treated with doxorubicin

2021-05-21 | GSE168687 | GEO

Fra2 ChIP-seq analysis of MCF7 cells treated with abemaciclib

Project description:We measured changes in AP-1 binding after treatment of MCF7 cells with abemaciclib

2020-09-01 | GSE157216 | GEO

Timecourse on MCF-7 cells treated with different concentration of doxorubicin

Project description:MCF-7 cells treated with 10μM doxorubicin for 4h followed by subsequent withdrawl of the drug and cultured up to 48h.Doxurubicin-treated cells and control cells were collected at 0,12,24,36,and 48h. Meanwhile,MCF-7 cells continuously exposed to a low dosage of doxorubicin at 0.1μM for 96h. Doxorubicin-treated cells and control cells were collected at 0,24,48,72 and 96h.

2019-04-11 | ST001170 | MetabolomicsWorkbench

JunB ChIP-seq analysis of MCF7 cells treated with abemaciclib

Project description:We measured changes in AP-1 factors binding after treatment of MCF7 cells with abemaciclib

2020-09-01 | GSE157218 | GEO

ChIP seq of mESC treated with doxorubicin

Project description:mESC were treated with doxorubicin and then histone modifications or p53 binding sites were analyzed

2021-05-21 | GSE168688 | GEO

Estrogen Receptor ChIP-seq analysis of MCF7 cells treated with abemaciclib

Project description:We measured changes in ER binding after treatment of MCF7 cells with abemaciclib

2020-09-01 | GSE157211 | GEO

RNA-seq analysis of MCF7 cells treated with abemaciclib, SR11302

Project description:We measured changes in gene expression in MCF7 with CDK4/6 and AP-1 inhibition by abemaciclib and SR11302, respectively.